Bank of New York Mellon’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-18,046
| Closed | -$14K | – | 4579 |
|
|
2022
Q3 | $14K | Sell |
18,046
-50
| -0.3% | -$39 | ﹤0.01% | 4480 |
|
|
2022
Q2 | $52K | Sell |
18,096
-36,418
| -67% | -$105K | ﹤0.01% | 4335 |
|
|
2022
Q1 | $343K | Buy |
54,514
+17,042
| +45% | +$107K | ﹤0.01% | 3938 |
|
|
2021
Q4 | $417K | Buy |
37,472
+835
| +2% | +$9.29K | ﹤0.01% | 3910 |
|
|
2021
Q3 | $598K | Buy |
36,637
+5,233
| +17% | +$85.4K | ﹤0.01% | 3705 |
|
|
2021
Q2 | $582K | Buy |
31,404
+15,731
| +100% | +$292K | ﹤0.01% | 3697 |
|
|
2021
Q1 | $237K | Sell |
15,673
-2,059
| -12% | -$31.1K | ﹤0.01% | 3997 |
|
|
2020
Q4 | $572K | Buy |
+17,732
| New | +$572K | ﹤0.01% | 3555 |
|